| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2025 | Apr 28, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 61.3 | +19,700 | 0.21% | ✗ | $31.5K |
| Apr 3, 2025 | Apr 7, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 65.0 | +32,475 | 0.34% | ✗ | $54.3K |
| Mar 27, 2025 | Mar 31, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 65.0 | +37,000 | 0.39% | ✗ | $65.6K |
| Mar 21, 2025 | Mar 24, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 92.5 | +433,400 | 4.77% | ✗ | $3.7M |
| Mar 12, 2025 | Mar 14, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 65.0 | +31,154 | 0.34% | ✗ | $64K |
| Mar 6, 2025 | Mar 10, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 90.0 | +410,877 | 4.04% | ✗ | $782.8K |
| Feb 4, 2025 | Feb 6, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 72.5 | +100,000 | 0.99% | ✗ | $162K |
| Jan 22, 2025 | Jan 23, 2025 | GOLD RESERVE LTD | 10% Owner | Buy | 72.5 | +56,700 | 0.57% | ✗ | $83.9K |
| Sep 28, 2022 | Sep 30, 2022 | Pasithea Therapeutics Corp. | Other | Buy | 87.5 | +64,357 | 3.73% | ✗ | $76.3K |
| Sep 1, 2022 | Sep 6, 2022 | Pasithea Therapeutics Corp. | Other | Buy | 90.0 | +88,901 | 5.44% | ✗ | $100.4K |
| Aug 29, 2022 | Aug 31, 2022 | Pasithea Therapeutics Corp. | Other | Buy | 78.8 | +22,828 | 1.42% | ✗ | $26.3K |
| Aug 17, 2022 | Aug 18, 2022 | Pasithea Therapeutics Corp. | Other | Buy | 95.0 | +155,773 | 10.70% | ✗ | $188.3K |